Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine Study in Paroxysmal Atrial Fibrillation
NCT03032965Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Oct 2011
- Primary completion
- Jul 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised trial of adenosine in Atrial fibrillation (AFib) (2 arms), sponsored by University of Michigan. Primary endpoint: Freedom From Any Atrial Arrhythmias. Started Oct 2011; status: completed.
02
Drugs
adenosine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03032965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03032965.